Skip to main content
OpenTrials

Clinical trial condition

Digestive System Diseases

Explore clinical trials studying Digestive System Diseases. Study availability and eligibility vary by location and protocol.

31,800 public trials 5,675 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Diseases trial results

Recruiting

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

NCT07071519

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Phoenix Children's Hospital /ID# 273015 Phoenix, Arizona, United States
  • Rady Children's Hospital /ID# 271873 San Diego, California, United States
  • University of California San Francisco - Mission Bay /ID# 273022 San Francisco, California, United States
  • Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue /ID# 271585 Miami, Florida, United States
View all 61 locations
View Trial Details
Recruiting

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

NCT05372614

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
View all 18 locations
View Trial Details
Recruiting

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

NCT04447911

Conditions
Brain Diseases, Central Nervous System Diseases, Digestive System Diseases, +21 more
Locations
  • University Hospital of Würzburg, med. Poliklinik Würzburg, Germany
  • Erasmus Universität Medisch Centrum Rotterdam, Department of Internal Medicine Rotterdam, Netherlands
  • Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland
  • University Hospital Basel Basel, Switzerland
View Trial Details
Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086

Conditions
Body Weight, Colitis, Colitis, Ulcerative, +15 more
Locations
  • Digestive Health Specialists Dothan, Alabama, United States
  • Smart Cures Clinical Research Anaheim, California, United States
  • Cedars-Sinai Medical Center Beverly Hills, California, United States
  • United Medical Doctors - Los Alamitos Los Alamitos, California, United States
View all 187 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 31 locations
View Trial Details
Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations
  • Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States
  • Avenzo Therapeutics Recruiting Site Los Angeles, California, United States
  • Avenzo Therapeutics Recruiting Site Denver, Colorado, United States
  • Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States
View all 19 locations
View Trial Details
Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

NCT07468071

Conditions
Advanced Solid Tumors Harboring the KRAS G12C Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Koto Ku, Tokyo, Japan
View all 17 locations
View Trial Details

Related conditions